UK's Spectris agrees sweetened KKR offer as takeover battle heats up
The London-headquartered company said it had agreed to a 41.75 pound per share deal with KKR just four days after backing a bid from Advent at 41 pound per share.
Shares in Spectris gained 1.4% in early trading.
The two private equity firms have been vying for control of the company for over a month after Spectris agreed to an initial offer from Advent in June.
Britain's subdued valuations and relative stability have attracted overseas buyers, with a flurry of bids in recent months highlighting appetite for UK assets.
Advent's initial bid came after Spectris' share price had declined by around half from a 2021 peak.
The KKR offer values Spectris' equity at 4.2 billion pounds, with an enterprise value of 4.8 billion pounds including debt.
The pace of takeovers of British companies has accelerated this year despite the turmoil triggered by U.S. tariffs, which weighed on global dealmaking in the months after so-called Liberation Day in early April.
There has since been a rebound, with the value of transactions in the first seven months of the year reaching $2.6 trillion, the highest for the period since the 2021 pandemic-era peak, according to data from Dealogic.
($1 = 0.7528 pounds)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
7 minutes ago
- Daily Mail
ANDREW NEIL: Rachel Reeves has spent like a drunken sailor. Now she's in a mad scramble for tax rises. This is what's coming... she risks tilting us into a death spiral
Britain's beleaguered Labour Government has begun a desperate scramble to determine which of our taxes should be jacked up – and by how much – in the autumn Budget. Even though we're now in the midst of the summer 'silly season', when political news tends to take a back seat to more frothy activities, Prime Minister Keir Starmer and Chancellor Rachel Reeves are already in cahoots to soften up worried financial markets and hard-pressed voters for major tax rises.
Daily Mail
10 minutes ago
- Daily Mail
EDEN CONFIDENTIAL: So what's the deal with birthday girl Beatrice's new business venture?
Earlier this year she became patron of Borne, a charity dedicated to unearthing the causes of premature birth – just the latest such role that Princess Beatrice has embraced in recent years. But never assume that the Duke and Duchess of York 's daughter feels able to spurn commercial opportunities. Though married to Edoardo Mapelli Mozzi, who reinvents properties in dazzling fashion for the intensely rich, Bea receives no money from the Sovereign Grant – the public fund for the monarch and working royals. So I'm intrigued that, in the week her parents' financial ventures and recreational pleasures were subjected to scrutiny in Andrew Lownie's biography, she's going into business with a thrusting performer from the World Economic Forum (WEF). That's the Swiss-based organisation which has been in turmoil ever since a series of lurid accusations were made against its founder – and, until April, chairman – Klaus Schwab. Bea's new enterprise is called Purpose Economy Intelligence Ltd, a rather impenetrable name which gives little clue to its line of business. Matters aren't made much clearer by its categorisation at Companies House. It's said to embrace 'business and domestic software development' and 'other information technology service activities', as well as 'management consultancy activities'. The princess, who turned 37 yesterday, is listed both as a director and owner of 45 per cent of the company. She has a familiar figure at her side – Olivia 'Libby' Horsley, who, since 2020 has been private secretary to both Bea and her younger sister, Princess Eugenie. Horsley is not a director. The third and final shareholder – who also owns 45 per cent of the business – is Luis Alvarado Martinez, a quadrilingual Spaniard who's described as 'head of strategic public-private-philanthropic partnerships' at the WEF, where he's worked since 2021. The third and final shareholder of Bea's new enterprise Purpose Economy Intelligence Ltd – who also owns 45 per cent of the business – is Luis Alvarado Martinez, a quadrilingual Spaniard He probably has rather a lot on his plate at the moment. An investigation, whose conclusions were leaked last month, alleges Martinez's former boss, Schwab, ran up £836,000 in expenses that were insufficiently linked to WEF activities to be justified, spent $50million on a luxurious villa, manipulated political research in a bid to discredit Brexit and put his crotch in close proximity to the face of a female member of staff. Schwab vehemently denies the allegations. But who wouldn't want to be a fly on the wall when Bea and Martinez compare notes? Naomi's kids are little fashionistas Naomi Campbell is refusing to let motherhood cramp her style. The supermodel, 55, reveals she spends thousands of pounds on luxury fashion for her children whenever she gets the chance – despite the fact they're only two and four years old. 'It used to be shopping for me – and then that got thrown out the window once my kids arrived,' she says. Naomi shared a video of a recent trip to Milan where she picked out a £1,140 jacket, a £760 cotton dress, £415 trainers, a £275 pink headband and a £230 blue wool scarf while shopping at Gucci. Posh's new green way to spice up your wardrobe Victoria Beckham is trying to keep up with the trend among young people for selling unwanted clothes on websites such as Vinted or Depop. I hear that the former Spice Girls singer has launched a facility on the website of her fashion label, Victoria Beckham, called The Re-Loved Archive, which gives customers the option to buy second-hand dresses and accessories from her previous collections for a discounted price or sell their older items in exchange for a credit towards new purchases. 'With The Re-Loved Archive, you can give your pre-loved Victoria Beckham pieces a second life,' says Sir David Beckham's 51-year-old wife, pictured left. 'Every item is carefully checked, authenticated and reconditioned. By selling what you no longer wear, you're helping to make fashion more circular.' This week, jeans originally costing £450 were sold on the site for £180, and a £520 jumper for £280. The move might be a much-needed financial boost for the label, which Posh Spice set up in 2008 and has accumulated losses exceeding £66 million. It did, however, make a profit for the first time last year. No other choice but Emma's mini-me for Dame's younger self Dame Emma Thompson and fellow producers on her latest film didn't need to look too far to find an actress to play the younger version of her character. They cast the Oscar winner's real-life daughter, Gaia Wise, 25. And yesterday the pair attended a screening of The Dead Of Winter at the Locarno Film Festival in Switzerland. Dame Emma, 66, plays a widow who becomes trapped in a kidnapping plot. 'Gaia plays her in the 'full of love' bit of her life,' her mother explains. 'I was in the 'my life is over, and I got to say goodbye' piece. She's grieving and something distracts her, and then she's back to where she started. It's such a beautiful circle.' Miers whips up perfect recipe for good service MasterChef winner Thomasina Miers, who co-founded the popular Mexican restaurant chain Wahaca, knows a thing or two about good service. And she has a recipe for improving British dining – and national morale: 'National Service, every single person spends six months in a restaurant kitchen.' The restaurateur, pictured right, adds: 'It teaches them the importance of teamwork, turning up on time, what happens when they don't turn up on time – letting people down – [and] the importance of social cohesion.' Miers, 49, says she's 'lucky' to have a job where 'what I do is very physical', noting that many other workers 'sit down for eight hours a day' and, if they work from home, 'don't go and see people'. What did lover leave to Maggi? Artist Maggi Hambling memorably remarked she celebrated turning 60 by buying 'a Bentley and having an affair'. More precisely, another affair, given that a few years earlier she had been entangled with Henrietta Moraes, who was herself in the last year of a rambunctious life which had encompassed three marriages and numerous bedroom adventures, including a protracted one with Lucian Freud. But, however intense her feelings for various lovers, none mattered more to Hambling than Victoria 'Tory' Lawrence, the woman who left her husband, racing commentator Lord Oaksey, to live with Hambling, and who died last October, aged 86. Tory's will, just published, indicates that her love for Hambling, 79, never faltered. Naming Hambling as one of her executors and trustees, it bequeaths her Tory's share in their Suffolk house, together with 'all articles of household, domestic or personal use, ornament or consumption'. Very modern manners Spencer Mathews set a Guinness World Record when he ran 30 marathons in 30 days last year. But the Made In Chelsea star's wife Vogue Williams, preserves her energy for nightclubbing. And the Irish podcaster, 39, has a tip on how to make it through the night: disco naps. 'I'd be in a club and set a timer for 15 minutes,' she explains. 'I'd go to the toilet, sleep and wait for the alarm to go off. One night I didn't wake up…and the bouncers came knocking on the door.' Quality family time for fledging Labour MP Being one of the comparatively few contemporary parliamentarians to have been consigned to boarding school – in his case, £60,336-a-year Radley College – fledgling Labour MP Henry Tufnell is inured to being away from home. But, in a message to supporters, he admits he's now looking forward to having some 'quality time with my family at the beach' in his Mid and South Pembrokeshire constituency. I trust that won't be at the expense of giving his parents a helping hand back in Gloucestershire. Someone's got to get the harvest in on the 2,000-acre family estate, still run by Henry's father Mark – a past president of the Country Land and Business Association. Henry, 33, can no doubt count on the support of his barrister wife – who has the splendidly ripe name of Poppy Rimington-Pounder... Accessory of the week Guests at a recent London party were bemused that Downton Abbey creator Julian Fellowes appeared to be carrying a garish blue cannister of a Finish cleaning product. 'It's not what it looks like,' Lord Fellowes, above, tells me. 'It's a snazzy mobile phone cover.' The Oscar winner's wife, Emma, explains: 'It was only £30. I bought it in Italy for fun.' Days after news that a set of ten commemorative Monty Python stamps are being released by the Royal Mail, estranged member Eric Idle is displeased. Following Python's official statement on the Royal Mail tribute, which also marks 50 years of the comedy troupe's movie classic The Holy Grail, the 82-year-old bitterly responds: 'Nice to know... be nice to be told earlier.' Idle's been feuding with fellow surviving members John Cleese, Sir Michael Palin and Terry Gilliam since publicly lambasting the management of the group's business affairs last year. Mainly based in LA, Idle returns to tour Britain next month but insists he'll never again reunite with Python colleagues.
Times
11 minutes ago
- Times
NHS drug pricing gives cold comfort to Big Pharma
When the government launched its Life Sciences Sector Plan on July 16 the tone was buoyant and the aim impressive: to turn 'cutting-edge research into real-world results: new treatments, faster diagnosis, and more lives saved'. The 'roadmap' to these sunlit uplands was constructed around three 'core pillars': to enable world-class scientific research and development; to attract global capital and grow UK companies; and to deliver better outcomes for patients in a more modern, preventive healthcare system. Few would dare to argue with these noble aspirations. And the UK's life sciences industry, which is worth £108 billion and employs more than 300,000 people, has indeed long been seen as a jewel in the country's economic crown. But the shadow of potential decline has fallen across it in recent years, with a cautionary tale attached: its name is AstraZeneca. Britain's most valuable public company, presently worth £170 billion, has deep roots in this country: it was the result of a 1999 merger between Sweden's Astra and the UK's Zeneca Group, itself an offshoot of the British chemical behemoth ICI. Its chief executive, Sir Pascal Soriot, in situ since 2012, has shown a strong commitment to nurturing scientific discovery. That yielded its most dramatic benefits during the Covid-19 pandemic when AstraZeneca's vaccine, developed with Oxford University, was a British success story. Yet since then its relations with the UK government have not all been smooth sailing. In 2021, as a response to Britain's 'discouraging' taxes, the company located a £320 million new factory in Ireland rather than England. Sir Pascal was also unhappy with the decision by Nice, England's drug-approval body, to reject the firm's breast cancer drug Enhertu on cost grounds, despite its adoption in Scotland. Perhaps the most dispiriting episode, however, involved AstraZeneca's decision to abandon a proposed £450 million expansion of its vaccine plant in Speke, near Liverpool, after the incoming Labour government threatened to slash the subsidies it was previously offered. There have been worrisome murmurs of relisting in the US. • AstraZeneca boss demands big rise in NHS drug spending Those examples — and the dissatisfaction they indicate — have echoes in the wider mood in the life sciences industry. Many pharmaceutical companies feel that the UK has moved from striking a necessarily hard bargain on NHS drug prices to a resistant mindset that overly restricts patients' access to new treatments. Last year Paul Hudson, the British chief executive of the French company Sanofi, lamented a UK system that is slow to pass on medical advances: for every 100 patients that get a new medicine within its first year of production in EU countries, he said, only 21 UK patients enjoy the same benefit. The share of the UK health budget spent on new medicines has fallen to less than 10 per cent, compared with 15 per cent in France and 17 per cent in Germany. Meanwhile, companies say, overly tight NHS price-capping on drugs is now threatening investment in Britain. Clearly a balance must be struck between NHS budgetary restraints and encouraging life-changing research and development. Yet the warnings from AstraZeneca suggest that the pharmaceutical industry is being viewed through too myopic and punitive a lens, because it is easier to seek discounts on drugs than it is to improve NHS efficiency.
